Clicky

Schrodinger, Inc.(SDGR)

Description: Schrödinger, Inc. provides chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. Schrödinger was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in August 1990 and is headquartered in New York, NY.


Keywords: Drug Discovery Materials Science Simulation Software Pre Clinical Development

Home Page: www.schrodinger.com

SDGR Technical Analysis

1540 Broadway
New York, NY 10036
United States
Phone: 212 295 5800


Officers

Name Title
Dr. Ramy Farid Ph.D. CEO, Pres & Director
Dr. Richard A. Friesner Ph.D. Co-Founder, Scientific Advisory Chairman and Director
Mr. Kenneth Patrick Lorton Exec. VP & CTO
Dr. Robert Lorne Abel Ph.D. Exec. VP, Chief Computational Scientist and Head of Modeling R&D
Dr. Karen Akinsanya Ph.D. Pres of R&D Therapeutics
Prof. William Goddard III Co-Founder & Scientific Advisor
Dr. Geoffrey Craig Porges MBBS Exec. VP & CFO
Mr. Shane Brauner Exec. VP & Chief Information Officer
Ms. Jaren Irene Madden Sr. VP of Investor Relations & Corp. Communications
Ms. Yvonne Tran Esq. Exec. VP, Chief Legal Officer & Sec.

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.5366
Price-to-Sales TTM: 8.321
IPO Date: 2020-02-06
Fiscal Year End: December
Full Time Employees: 664
Back to stocks